Healthcare
ABBV
AbbVie Inc.
$246.04+0.89%
Add to Watchlist
About AbbVie Inc.
AbbVie is a pharmaceutical company that was spun off from Abbott Laboratories. Their former blockbuster drug Humira (for arthritis and autoimmune diseases) has lost patent protection, but they have been replacing that revenue with newer drugs like Skyrizi and Rinvoq. They also have a growing portfol…
Full research is for ConvictionStocks members
Unlock Full AccessWhat Analysts Think
Full research is for ConvictionStocks members
Unlock Full AccessRecent News
Full research is for ConvictionStocks members
Unlock Full AccessGet the free weekly market digest
The week's biggest movers, every Sunday. No spam.
Related Research
More Healthcare stocks to explore